NexImmune, Inc. (NASDAQ:NEXI – Get Rating) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 344,000 shares, a drop of 18.1% from the February 28th total of 419,800 shares. Approximately 2.0% of the company’s shares are short sold. Based on […]